<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21126">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02831868</url>
  </required_header>
  <id_info>
    <org_study_id>415-16</org_study_id>
    <nct_id>NCT02831868</nct_id>
  </id_info>
  <brief_title>Safety, Tolerability and Efficacy of HAVAI, a Minimal Invasive Double Anchor and Suture Orthopedic Implant Fixation Device Implant and Assistive Tools for Correction of Inter-metatarsal Angle</brief_title>
  <official_title>Multi Center, Open-label, Singe Arm, Study Designed to Evaluate Safety, Tolerability and Efficacy of HAVAI, a Minimal Invasive Double Anchor and Suture Orthopedic Implant Fixation Device Implant and Assistive Tools for Correction of Inter-metatarsal Angle in Subjects Suffering From Mild to Moderate Hallux Valgus Deformity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the safety, tolerability and efficacy of the HAVAI device as a minimally
      invasive double anchor and suture orthopedic implant fixation device for IMA reduction in
      cases of HV deformities when the IMA is greater than 120 and less than or equal 200.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>An improvment in IMA angel</measure>
    <time_frame>50 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hallux Valgus</condition>
  <arm_group>
    <arm_group_label>EXP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HAVAI</intervention_name>
    <arm_group_label>EXP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult males and female subjects, aged 20 to 75 years old, inclusive, at screening
             visit.

          2. Subject weighing &lt;100 kg and body mass index (BMI) &lt;32 kg/m2.

          3. Subjects with confirmed diagnosis of HV deformity based on radiography assessment of
             IMA &gt; 12ยบ and less than or equal to 20.

          4. Subjects who need distal osteotomy of the MT1 as part of their surgery.

          5. Able and willing to comply with the requirements of the protocol.

          6. Able to understand and sign written informed consent to participate in the study.

        Exclusion Criteria:

          1. Contraindication to implantation procedure

          2. History of:

               -  Diabetes mellitus

               -  Claudication, known peripheral vascular disease or no palpable pulses (DP or
                  TP).

               -  Known rheumatoid disease.

               -  Previously diagnosed gout or any systemic inflammatory arthropathy.

               -  X-ray evidence of osteoarthritis of MTPJ-1.

               -  Previous neorological conditions associated with spasticity.

               -  Prior operation on MT1 or MT2.

               -  Fracture (past or present) of MT1 or MT2.

          3. Known osteoarthritis.

          4. Aseptic necrosis or any deformity of MT2 head.

          5. Pregnant women or women with childbearing potential who are not obliged to take any
             contraception measures

          6. Subject is currently enrolled in or has not yet completed at least 30 days since
             ending other investigational device or drug study(s), or subject is receiving other
             investigational agent(s)

          7. Any condition that may jeopardize study participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aharon Finestone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assaf Harofe</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Billig, MBA</last_name>
    <phone>02-6553333</phone>
    <email>dbillig@bonfixmedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ayelet Goldwasser, CTA</last_name>
    <phone>052-5771144</phone>
    <email>ayelet@duet-medical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bonfix Ltd</name>
      <address>
        <city>Jerusalem</city>
        <zip>91391</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Billig, MBA</last_name>
      <phone>02-6553333</phone>
      <email>dbillig@bonfixmedical.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 12, 2016</lastchanged_date>
  <firstreceived_date>July 11, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hallux Valgus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
